SE7413530L - - Google Patents

Info

Publication number
SE7413530L
SE7413530L SE7413530A SE7413530A SE7413530L SE 7413530 L SE7413530 L SE 7413530L SE 7413530 A SE7413530 A SE 7413530A SE 7413530 A SE7413530 A SE 7413530A SE 7413530 L SE7413530 L SE 7413530L
Authority
SE
Sweden
Prior art keywords
member selected
group consiting
alkyl
carbon atoms
methylene
Prior art date
Application number
SE7413530A
Other languages
English (en)
Other versions
SE412389B (sv
Inventor
Michiro Inoue
Masayuki Ishikawa
Takashi Tsuchiya
Takio Shimamoto
Original Assignee
Michiro Inoue
Masayuki Ishikawa
Takashi Tsuchiya
Takio Shimamoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12126073A external-priority patent/JPS5732065B2/ja
Priority claimed from JP12175773A external-priority patent/JPS5724786B2/ja
Application filed by Michiro Inoue, Masayuki Ishikawa, Takashi Tsuchiya, Takio Shimamoto filed Critical Michiro Inoue
Publication of SE7413530L publication Critical patent/SE7413530L/xx
Publication of SE412389B publication Critical patent/SE412389B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7413530A 1973-10-30 1974-10-28 Forfarande for framstellning av 1-ftalazon-derivat. SE412389B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12126073A JPS5732065B2 (xx) 1973-10-30 1973-10-30
JP12175773A JPS5724786B2 (xx) 1973-10-31 1973-10-31

Publications (2)

Publication Number Publication Date
SE7413530L true SE7413530L (xx) 1975-05-02
SE412389B SE412389B (sv) 1980-03-03

Family

ID=26458679

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413530A SE412389B (sv) 1973-10-30 1974-10-28 Forfarande for framstellning av 1-ftalazon-derivat.

Country Status (20)

Country Link
US (1) US3963716A (xx)
AR (1) AR205004A1 (xx)
CA (1) CA1029377A (xx)
CH (2) CH611282A5 (xx)
DD (1) DD119231A5 (xx)
DE (1) DE2451417C3 (xx)
DK (1) DK134345B (xx)
ES (1) ES431454A1 (xx)
FI (1) FI59402C (xx)
FR (1) FR2248841B1 (xx)
GB (1) GB1459606A (xx)
HU (1) HU168797B (xx)
IE (1) IE39831B1 (xx)
IL (1) IL45675A (xx)
IN (1) IN139552B (xx)
LU (1) LU71191A1 (xx)
NL (1) NL7414186A (xx)
PH (1) PH10519A (xx)
SE (1) SE412389B (xx)
YU (1) YU289774A (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120960A (en) * 1973-10-31 1978-10-17 The Boots Company Limited Therapeutic agents
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4464532A (en) * 1979-07-31 1984-08-07 Nippon Kayaku Kabushiki Kaisha Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
JPS5668609A (en) * 1979-11-07 1981-06-09 Nippon Kayaku Co Ltd Phthalazinol preparation
JPS58116471A (ja) * 1981-12-29 1983-07-11 Nippon Kayaku Co Ltd ４−ヒドロキシメチル−１−フタラゾンエステル誘導体およびその塩
GB2127805A (en) * 1982-09-13 1984-04-18 Showa Denko Kk Phthalazones
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
ES2067508T3 (es) * 1988-08-19 1995-04-01 Warner Lambert Co Dihidroisoquinolinonas sustituidas y compuestos relacionados como potenciadores de los efectos letales de la radiacion y de ciertos agentes quimioterapeuticos; compuestos seleccionados, analogos y proceso.
US5177075A (en) * 1988-08-19 1993-01-05 Warner-Lambert Company Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
DE4333761A1 (de) * 1993-10-04 1995-04-06 Luitpold Pharma Gmbh Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
ES2525748T3 (es) 2009-11-13 2014-12-29 Toray Industries, Inc. Agente terapéutico o profiláctico para la diabetes
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
KR102456567B1 (ko) 2013-08-09 2022-10-19 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116430B2 (xx) * 1971-08-05 1976-05-24
US3870792A (en) * 1972-07-24 1975-03-11 Michiro Inoue Certain dihydrophthalizines for treating hemorrhage and thrombosis

Also Published As

Publication number Publication date
CH611282A5 (xx) 1979-05-31
FR2248841A1 (xx) 1975-05-23
FI315774A (xx) 1975-05-01
PH10519A (en) 1977-05-26
HU168797B (xx) 1976-07-28
ES431454A1 (es) 1976-10-16
GB1459606A (en) 1976-12-22
FI59402B (fi) 1981-04-30
IL45675A0 (en) 1974-11-29
IL45675A (en) 1978-10-31
DE2451417B2 (de) 1980-05-14
YU289774A (en) 1983-01-21
DE2451417A1 (de) 1975-05-07
DK134345B (da) 1976-10-25
FR2248841B1 (xx) 1978-07-28
SE412389B (sv) 1980-03-03
DK561874A (xx) 1975-07-07
DD119231A5 (xx) 1976-04-12
DE2451417C3 (de) 1981-01-29
DK134345C (xx) 1977-03-21
FI59402C (fi) 1981-08-10
IN139552B (xx) 1976-07-03
IE39831L (en) 1975-04-30
AR205004A1 (es) 1976-03-31
CH610892A5 (xx) 1979-05-15
NL7414186A (nl) 1975-05-02
IE39831B1 (en) 1979-01-03
AU7295474A (en) 1976-03-11
US3963716A (en) 1976-06-15
CA1029377A (en) 1978-04-11
LU71191A1 (xx) 1975-04-17

Similar Documents

Publication Publication Date Title
SE7413530L (xx)
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES422001A1 (es) Un procedimiento para la preparacion de nuevas imidazotria-zinas.
EG11259A (en) Preparation of pharmacologically active compounds as depresent for histamin recepters
IE41528L (en) Furfuryl-benzomorphane derivatives.
ES421430A1 (es) Procedimiento para producir derivados carbostirilo.
SE7408498L (xx)
ES411112A1 (es) Procedimiento de preparacion de nuevos derivados del 1'1- difenil-etileno.
ES416891A1 (es) Un procedimiento de preparacion de derivados de acido suc- cinico.
IE41767L (en) Dihydroergopeptine derivatives
ES428005A1 (es) Procedimiento para la preparacion de derivados de 3-4-dihi-dro-2h-naftalenom-(1)-5-oxi-propil-piperazina.
GB1084700A (en) Thiosemicarbazones and their production
ES537541A0 (es) Acidos 1, 3-dioxan-4-ilalquenoicos
GB1284379A (en) Substituted 4,5-diphenyloxazoles
ES427115A1 (es) Procedimiento de preparacion de nuevos derivados del acido acetico.
IE41201L (en) Cyclohexanetetrol esters
GB1459518A (en) Process for the preparation of bicyclo 4,3,0-nonenols
ES448389A1 (es) Procedimiento para la preparacion de isotiazolilureas susti-tuidas.
ES444369A1 (es) Procedimiento de preparacion de nuevos derivados dienicos dela serie del androstano.
GB1433103A (en) Pharmacologically active pyrrolodiazepines
ES419386A1 (es) Un procedimiento para la preparacion de nuevos derivados deindenopirrol.
GB1112909A (en) Ergoline derivatives
IE39233L (en) Pyridino-dibenzo-azepine,-diazepine, -oxazepine and¹-thiazepine derivatives
GB1513280A (en) Therapeutic pyrazole derivatives
GB1441873A (en) Diamino-benzophenones

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7413530-2

Effective date: 19880627

Format of ref document f/p: F